
Exxon Mobil, Chevron, and AbbVie are the three Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their earnings to shareholders as cash payments (dividends), typically quarterly. Investors use them for income and total-return strategies, evaluating metrics like dividend yield and payout ratio and the company’s ability to sustain payments. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
Read Our Latest Research Report on CVX
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Read Our Latest Research Report on ABBV
Featured Articles
- MarketBeat’s Top Five Stocks to Own in January 2026
- What’s the Best Way to Buy Gold in 2026?
- Is Abbott’s January Pullback a Good Time to Buy?
- New Year, New Growth: 3 Stocks Under $2B Breaking Out in 2026
- Atlassian Has Been Crushed—But the Setup Into Earnings Is Shifting
- MarketBeat Week in Review – 01/19 – 01/23
